Task: Answer the multiple choice question.
Question: Which drug exhibits a -7.424% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a CC(C)n1cnnc1SCC(=O)NC(=O)c1ccccc1
b CCOC(=O)N1CCN(C(=O)COc2ccc(Cl)c(C)c2)CC1
Answer: b. CCOC(=O)N1CCN(C(=O)COc2ccc(Cl)c(C)c2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOC(=O)N1CCN(C(=O)COc2ccc(Cl)c(C)c2)CC1
CCOC(=O)N1CCN(C(=O)COc2ccc(Cl)c(C)c2)CC1
ethyl4-[2-(4-chloro-3-methylphenoxy)acetyl]piperazine-1-carboxylate